4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-17-002011
Chief Scientific Officer sold 5,000 shares at $15.00 ($75,000)
- Chief Scientific Officer acquired 732 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ordentlich Peter · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-05-17 | Exercise or conversion : show line 1 in the form | +732 | $3.08 | $2,255 | 5,000 | D |
| 2017-05-17 | Sale : show line 2 in the form | −5,000 | $15.00 | $75,000 | 0 | D |
| Open-market sales · 5,000 sh · avg $15.00 · $75,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-05-17 | Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) | −732 | 0 | D |
Loading xslF345X03/primarydocument.xml…